| 1 |
selective estrogen receptor degraders
(73 times)
|
Chemistry
(24 times)
|
SERMs (21 times)
ER (14 times)
AIs (13 times)
|
2000 Modulation of oestrogen action by receptor gene inhibition.
|
| 2 |
selective ER downregulators
(8 times)
|
Molecular Biology
(3 times)
|
AIs (4 times)
SERMs (4 times)
ERalpha (3 times)
|
2017 Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer.
|
| 3 |
selective ER degraders
(3 times)
|
Neoplasms
(2 times)
|
ER (2 times)
BC (1 time)
CERANs (1 time)
|
2011 The turnover of estrogen receptor alpha by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy.
|
| 4 |
selective ERalpha degraders
(1 time)
|
Chemistry
(1 time)
|
ERalpha (1 time)
HDAC (1 time)
THIQ (1 time)
|
2021 Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer.
|
| 5 |
Selective Estrogen Degraders
(1 time)
|
Pharmacology
(1 time)
|
ER (1 time)
SERMs (1 time)
|
2010 The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.
|
| 6 |
selective estrogen down regulators
(1 time)
|
Gynecology
(1 time)
|
ER (1 time)
SERMs (1 time)
|
2009 Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
|
| 7 |
selective estrogen receptor modulators or degraders
(1 time)
|
Neoplasms
(1 time)
|
ABC (1 time)
|
2022 AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2- advanced breast cancer.
|
| 8 |
Services for Dependence
(1 time)
|
Gastrointestinal Diseases
(1 time)
|
DAA (1 time)
HCV (1 time)
HCV-Ab (1 time)
|
2021 Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient-centered program from Italy.
|
| 9 |
Severely Energy-Restricted Diets
(1 time)
|
Medicine
(1 time)
|
---
|
2021 Dietary adherence and program attrition during a severely energy-restricted diet among people with complex class III obesity: A qualitative exploration.
|
| 10 |
such as tamoxifen, and degraders
(1 time)
|
Pharmaceutical Preparations
(1 time)
|
ER (1 time)
|
2021 Selective estrogen receptor degraders (SERDs) and covalent antagonists (SERCAs): a patent review (2015-present).
|
A Search Service for Abbreviation / Long Form